Health Care Select Sector SPDR Fund (XLV)
| Assets | $37.64B |
| Expense Ratio | 0.09% |
| PE Ratio | 23.54 |
| Shares Out | 271.62M |
| Dividend (ttm) | $2.20 |
| Dividend Yield | 1.59% |
| Ex-Dividend Date | Mar 18, 2024 |
| Payout Ratio | 37.32% |
| 1-Year Return | +3.73% |
| Volume | 9,667,062 |
| Open | 139.15 |
| Previous Close | 138.43 |
| Day's Range | 138.45 - 139.34 |
| 52-Week Low | 122.59 |
| 52-Week High | 148.27 |
| Beta | 0.55 |
| Holdings | 66 |
| Inception Date | Dec 16, 1998 |
About XLV
Fund Home PageThe Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund tracks health care stocks from within the S&P 500 Index, weighted by market cap. XLV was launched on Dec 16, 1998 and is issued by State Street.
Top 10 Holdings
55.34% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 11.59% |
| UnitedHealth Group Incorporated | UNH | 8.88% |
| Johnson & Johnson | JNJ | 6.83% |
| Merck & Co., Inc. | MRK | 6.18% |
| AbbVie Inc. | ABBV | 5.66% |
| Thermo Fisher Scientific Inc. | TMO | 4.07% |
| Abbott Laboratories | ABT | 3.56% |
| Danaher Corporation | DHR | 3.03% |
| Pfizer Inc. | PFE | 2.79% |
| Amgen Inc. | AMGN | 2.74% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 18, 2024 | $0.52294 | Mar 21, 2024 |
| Dec 18, 2023 | $0.59773 | Dec 21, 2023 |
| Sep 18, 2023 | $0.53952 | Sep 21, 2023 |
| Jun 20, 2023 | $0.54244 | Jun 23, 2023 |
| Mar 20, 2023 | $0.48914 | Mar 23, 2023 |
| Dec 19, 2022 | $0.55613 | Dec 22, 2022 |
News
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
How a Biden-Trump rematch can keep healthcare ETFs afloat this election year
Hello! This is MarketWatch reporter Isabel Wang bringing you this week's ETF Wrap. In this week's edition, we look at healthcare ETFs, which have taken a breather at the start of April, pausing their ...
This was a hot and promising sector for 2024. That's over, says one strategist.
Much chatter has been devoted to what's needed for the U.S. stock market rally to continue this year. A big one on the to-do list?
Consider an Equal Weight Strategy Amid Renewed Volatility
Capital markets appear content with playing the rate cut waiting game as the S&P 500 continues to rise to new highs. Meanwhile, renewed volatility could make investors reconsider adding an equal weigh...
Healthcare Investors Aren't Scared of Trump or Biden
Health stocks are off to their best start since 2017, despite a history of underperformance in election years.
Health care has more upside ahead, says BTIG's Jonathan Krinsky
Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss his call for tech exhaustion ahead.
Health care's underperformance last year sets it up well for 2024, says Mara Goldstein
Mara Goldstein, Biotech Analyst at Mizuho, discusses health care's outperformance this week.
Final Trades: Pfizer, Autodesk, Abbvie and XLV
The 'Halftime Report' Investment Committee members Liz Young, Karen Firestone, Bill Baruch and Josh Brown give their top picks to watch for the second half.
Charts turn bullish on health-care stocks as sector takes early lead in 2024
Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h...
Here are Wall Street's favorite stocks in the sector expected to grow profits the most in 2024
Each earnings reporting season, you can count on a flurry of articles with headlines saying companies “beat” consensus estimates for quarterly profits. But that “success” alone means nothing.
Healthcare Stocks Are Trying to Break Out. What They Need Now.
If the economy were to start showing clear signs of weakening, defensive healthcare stocks such as UnitedHealth, Humana, and Cigna would look relatively attractive.
3 Charts For Investors to Watch Wednesday: Rivian, Norwegian Cruise Line, XLV ETF
Here's our daily look at three charts connected to recent news-driven price moves, with key technical levels to monitor.
Right now healthcare isn't showing any signs of turning around, says Truist's Keith Lerner
Keith Lerner, Truist co-chief investment officer and Bob Doll, Crossmark Global Investments chief investment officer, join 'Closing Bell Overtime' to talk the day's market action, their outlook for 20...
Biotech Stocks Are Rallying, but the Outlook Isn't Good
The XBI has been climbing this month. On Tuesday it jumped 5.4% to close at $70.91.
Chart Master: Sell healthcare, hold off on buying Pfizer
Carter Worth, Worth Charting, joins 'Fast Money' to talk his take on the healthcare space, Pfizer's recent performance and more.
Final Trades: Alphabet, NXP Semi & more
The "Halftime Report" traders give their top picks to watch for the second half.
The Bond Sell-Off Might Be Over. Buy These Stocks to Win.
Bond yields are showing signs that they have peaked. If they keep dropping, it would make a host of stocks look attractive including Duke Energy, Coca-Cola, Procter & Gamble, and Johnson & Johnson.
The Case For Healthcare Stocks
It stands to reason that investing in healthcare is less volatile than investing in other sectors. After all, people get sick in both good times and bad.
Fundamentals for M&A in healthcare sector remain really strong, says Guggenheim's Mehta
Punit Mehta, Guggenheim Securities head of healthcare investment banking, joins 'Squawk on the Street' to discuss the healthcare M&A market, how Mehta sees the growth of the new class of weight-loss d...
Final Trades: Uber, Energy & more
The "Halftime Report" traders give their top picks to watch for the second half.
Call of the day: The health care trade
CNBC's Halftime traders Steve Weiss, Liz Young, Joe Terranova, and Brian Belski discuss the call of the day: health care.
CI Barrett's Amy Kong details her tech and healthcare stock playbook
Amy Kong, CI Barrett Asset Management CIO, joins 'Closing Bell' to discuss navigating the tech rally and health care names.
Healthcare sector should see a return to earnings growth next year, says Fort Pitt's Dan Eye
Dan Eye, Fort Pitt Capital Group CIO, joins 'Closing Bell OVertime' to discuss buying opportunities in the Healthcare sector and why he says the sector should see a return to earnings growth next year...